Exploring Transitioning To Systemic Therapy In Hcc
Let's dive into the details surrounding Transitioning To Systemic Therapy In Hcc.
- Arndt Vogel, MD, outlines the benefits and risks of
- Lorenza Rimassa, MD, Hunimed University, Milan, Italy, discusses the
- After reviewing the historic management of
- Richard S. Finn, MD, comments on the use of liver-directed
- Systemic Therapy
In-Depth Information on Transitioning To Systemic Therapy In Hcc
Panelists Richard S. Finn, MD; Richard H. Marshall, MD; Amit Singal, MD, MSCS; and Arndt Vogel, MD, PhD, highlight key factors ... Given several patient factors and Catherine T. Frenette, MD, and Darren S. Sigal, MD, discuss when it is the right time to move to Panelists Ghassan K. Abou-Alfa, MD; Amit G. Singal, MD; and Richard Finn, MD, outline patient and disease factors to consider ...
Advanced
That wraps up our extensive overview of Transitioning To Systemic Therapy In Hcc.